Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979807 · ClinicalTrials.gov registry record
A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 11,296
- Enrollment target
NCT03979807 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 11,296 participants.
The verdict
NCT03979807 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 11,296 participants
- Enrollment target
Study Summary
To compare the persistence in using two different medications from the same drug class (LAMA/LABA FDC) which are delivered through different devices, a dry-powder inhalers (DPI) and Soft Mist Inhalers (SMI).
Interventions
- DRUG Umeclidinium/ Vilanterol
- DRUG Olodaterol/Tiotropium Bromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,296 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2019-06-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03979807
The ClinicalTrials.gov registry entry for NCT03979807 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11,296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Umeclidinium/ Vilanterol is the first listed.
NCT03979807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03979807 about?
NCT03979807 is a clinical study titled "A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)". To compare the persistence in using two different medications from the same drug class (LAMA/LABA FDC) which are delivered through different devices, a dry-powder inhalers (DPI) and Soft Mist Inhalers (SMI).
What is the current status of trial NCT03979807?
This trial is currently completed. The enrollment target is 11,296 participants. The study started on 2019-06-10. Estimated completion is 2019-06-11.
What interventions are being tested in trial NCT03979807?
The interventions under investigation include: Umeclidinium/ Vilanterol (DRUG), Olodaterol/Tiotropium Bromide (DRUG).
Who is sponsoring clinical trial NCT03979807?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.